Specialized Nutrition in China: a Strong and Sustainable engine for growth - Bridgette HELLER - Danone
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Investor Seminar October 22, 2018 Specialized Nutrition in China: a Strong and Sustainable engine for growth Bridgette HELLER EVP, Danone Specialized Nutrition
Bridgette Heller 3 years at Danone 2016 EVP Specialized Nutrition 2010 EVP Consumer Care at Merck & Co 2005 Global President Baby Global Business Unit at Johnson & Johnson Prior to 2005 Senior positions at Kraft Foods I 2 I
context short term mid-long term China, a key Maintaining Leadership Great potential growth engine in a shifting landscape to capture new opportunities
context short term mid-long term China, a key Maintaining Leadership Great potential growth engine in a shifting landscape to capture new opportunities
China is large and growing part of Specialized Nutrition Portfolio context China, a key short term Maintaining mid-long term Great potential growth engine Leadership to capture new in a shifting opportunities landscape Specialized Nutrition Greater China Net sales ~ €7 bn Net sales Greater China AMN ELN CAGR AMN ELN Rest of the World 2014 2015 2016 2017 pediatric nutrition adult nutrition Infant Milk Formula (IMF) Allergy Management Enteral Nutrition & TOP3 Player Neocate Nutricia # 1 Aptamil #1 Brand #1 Brand with HCP’s Adult Nutrition Brand partnership
10 years of massive growth of IMF market context China, a key short term Maintaining mid-long term Great potential growth engine Leadership to capture new in a shifting opportunities landscape Greater China IMF Market €21bn Infant Milk Formula Global Market Baby births increase Urbanization & middle class 07 08 09 10 11 12 13 14 15 16 17 Safety YOY Growth Concerns Greater China Rest of the world Premiumi- zation 07 08 09 10 11 12 13 14 15 16 17 Source: Euromonitor Packaged foods value Source: value, Nielsen, Smartpath
We outperformed category while building a more context China, a key short term Maintaining mid-long term Great potential sustainable IMF business model growth engine Leadership to capture new in a shifting opportunities landscape Market Share Danone route-to-market Value% Share of Net sales Indirect Multinationals (ex Danone) Danone Direct Chinese top-4 Other 2018 MAT 2015 2018 Est Source: Nielsen & smartpath IMF category ; Internal netsales
We are successfully building Direct channels to address context China, a key short term Maintaining mid-long term Great potential sustainability of RTM growth engine Leadership to capture new in a shifting opportunities landscape Direct China Direct International Net sales Net sales increase in sales vs 2014 2014 2015 2016 2017 2018 EST 2014 2015 2016 2017 2018 EST Source: internal
We established IMF leadership leveraging key specific context China, a key short term Maintaining mid-long term Great potential capabilities to win in China growth engine Leadership to capture new in a shifting opportunities landscape Omnichannel Reach Strong Global Brands Mom & Champion exposure-led parenting to Reconnect Chinese families to nature to Cross Border Baby Ecommerce become the No.1 culturally resonant become the No.1 socially responsible Stores parenting brand parenting brand (CBE) (MBS) Ecommerce We Chat Modern Friends Trade & Family IMF IMF Brand Brand
We have also built strong leadership both in pediatric allergy context China, a key short term Maintaining mid-long term Great potential and in adult hospital nutrition growth engine Leadership to capture new in a shifting opportunities landscape Allergy Management Market Enteral Nutrition Market HCP recommended Hospital Nutrition brand CAGR brand CAGR 2014 2015 2016 2017 2014 2015 2016 2017 Source: internal
context short term mid-long term China, a key Maintaining Leadership Great potential growth engine in a shifting landscape to capture new opportunities
Performance softening after four quarters of exceptional growth context China, a key short term Maintaining mid-long term Great potential growth engine Leadership to capture new in a shifting opportunities landscape China Specialized Nutrition Quarterly growth rate % YOY change 2015 2015 2015 2015 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 2018 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Source: internal, like-for-like Net Sales year on year evolution
In the short term, a few factors putting pressure context China, a key short term Maintaining mid-long term Great potential Market is expected to continue to grow growth engine Leadership to capture new in a shifting opportunities landscape continued shrinking regulatory baby pool changes category growth Impacted by Reinforced regulation demographic and of our categories lifestyle trends
Demographic and lifestyle trends are impacting growth context China, a key short term Maintaining mid-long term Great potential of IMF category growth engine Leadership in a shifting landscape to capture new opportunities China Fertile Population (15-49yo) Mn, 2005-2020E 400 China New-born Baby Population (MN), 2013-2017 380 360 Fertile female 17.9 340 The fertile population would population 17.2 16.9 have a ~20mn decrease from 16.4 16.6 2016 to 2020 320 300 '05 '07 '09 '11 '13 '15 '17 '19 Birth Willingness of 15-49yo Women (currently no child): %, 2012-2017 10 8.3 8.3 7.8 7.2 8 6.8 5.9 2013 2014 2015 2016 2017 6 4 2 Fertile Population - No. of women in reproductive age (15-49 years old) 0 Birth willingness - % of fertile age woman who gave 1st child birth at given year 2012 2013 2014 2015 2016 2017 Source: Government; Internal analysis & research
Accelerated trend of regulation of our categories in China context China, a key short term Maintaining mid-long term Great potential growth engine Leadership to capture new in a shifting opportunities landscape 2018 Developments New IMF national New process for New E-commerce standards in draft drug license law promulgated 2008 2013 2015 2016 2017 2018 renewal Note: SAMR – State Authority for Market Regulation; FSMP – Food for Special Medical Purposes
context short term mid-long term China, a key Maintaining Leadership Great potential growth engine in a shifting landscape to capture new opportunities
Moving forward, Danone SN well positioned to capitalize context China, a key short term Maintaining mid-long term Great potential on significant opportunities within a changing China market growth engine Leadership to capture new in a shifting opportunities landscape Our pillars potential growth drivers Right Brands & Strategies Evolving Low tier Premium Categories consumer city preferences offerings beyond IMF expansion Right Right Categories Capabilities
We are in the Right Categories with potential for growth context China, a key short term Maintaining mid-long term Great potential growth engine Leadership to capture new in a shifting opportunities landscape Right Categories Key Categories Expected 3Y category growth dynamic Low to Infant Milk Mid Formula Single digit Double First Diet Digit Condition Double Related Digit Nutrition1 Enteral High Nutrition single digit Source: Internal analysis and estimates Note: 1. Pediatric areas (Allergy, GI, Growth)
We have the Right Brands to drive consumer preference context China, a key short term Maintaining mid-long term Great potential in all of these growth categories growth engine Leadership to capture new in a shifting opportunities landscape Right Brands & Strategies Scientifically advanced – immune function Hong Kong Premiumness, → ready for challenges” better absorption Infant Milk Formula Infant Milk Formula Condition Related Nutrition Baby Food Dutch Heritage, Rooted in Nature Leading edge organic for strong growth Baby Food Infant Milk Formula Infant Milk Formula Condition Related Nutrition Condition Related Nutrition #1 allergy globally Strength, Muscle Condition Related Nutrition Condition Related Nutrition Faltering growth Cognition Our Medical Masterbrand Condition Related Nutrition Enteral Feeding Disease related malnutrition
We have the Right Strategies to meet the evolving needs context China, a key short term Maintaining mid-long term Great potential and preferences of Millennial Chinese parents growth engine Leadership to capture new in a shifting opportunities landscape Right Brands & Strategies Shifts in consumer motivations 2016 2018 H1 Authenticity & Safety Brand image Formula Functional benefits Source: Market research
Our Brands & Strategies are well suited to address untapped context China, a key short term Maintaining mid-long term Great potential opportunity in ultra-premium IMF segments growth engine Leadership to capture new in a shifting opportunities landscape Right Key Player IF Portfolio price ranges Brands & Strategies (Combined Channel) RMB/KG 650 Aptamil 600 Platinum Ultra 550 Premium+ 500 450 Ultra 400 Aptamil Premium 350 Platinum 300 Net sales Super Aptamil Premium Classic > x2 250 YTD 200 Nutrilon Mainstream Classic 150 100 Danone Multinational Multinational Multinational Chinese Chinese A B C Player A Player B Source: Nielsen; Smartpath IMF category, IF stage
We are prepared to leverage an innovative, benefit-focused, context China, a key short term Maintaining mid-long term Great potential global portfolio to extend our presence in ultra premium. growth engine Leadership to capture new in a shifting opportunities landscape Right Brands & Strategies Science-based Benefits Ingredient-based Benefits
Our Brands & Strategies are well suited to address untapped context China, a key short term Maintaining mid-long term Great potential opportunity in condition related or “tailored nutrition” growth engine Leadership to capture new in a shifting opportunities landscape Right Brands & Strategies Penetration vs Prevalence Opportunity to leverage our scientific capabilities Leadership in Cow’s Milk Allergy Prevalence EUR 1.3 management Penetration billion — Tailored Nutrition Strong HCP & KOL credibility +30% — growth Research capabilities to localize science Gastro-Intestinal Allergy Cow’s Milk Pre-term Disorders risk Allergy birth ~+50% ~+10% ~+30% ~+30% (Value growth by area) Source: Internal estimates & research; Nielsen & Smartpath tailored nutrition market MAT2018
Again, we will adapt and leverage our global portfolio context China, a key short term Maintaining mid-long term Great potential tailored to specific conditions & medical needs growth engine Leadership to capture new in a shifting opportunities landscape Right Brands & Strategies APTAMIL PROSYNEO APTAMIL PEPTI NEOCATE SYNEO Hypo-Allergenic, Partially Hydrolyzed Formula Amino Acid-Based Formula for infants for infants at-risk of cow’s milk allergy SYNEO diagnosed with severe Cow’s Milk Allergy Whey-based, Extensively Hydrolyzed (CMA) and/or Multiple Food Allergy (MFA). Formula for infants diagnosed with Cow’s Milk Allergy (CMA). A complete portfolio in Allergy prevention and management Challenged growth due Faltering growth due to Gastro-intestinal disorders to pre-term birth disease and/or disability
25 We’ll leverage the right brands, strategies and medical context China, a key short term Maintaining mid-long term Great potential expertise to continue capturing potential beyond IMF` growth engine Leadership to capture new in a shifting opportunities landscape Right Brands & Strategies Enteral & Parenteral Nutrition AFSMP New Regulatory Framework AFSMP New Regulatory Framework market evolution New regulatory framework, opening a new self- pay Medical Food Category in 2018, linked to a growing elderly population 2 — Global reference benchmark Opportunity to make medical nutrition accessible in community — Supporting chronic disease management eg. >+10% cancer care, geriatrics 2018 YTD Parenteral Enteral #1 Hospital Nutrison powder improves Nutrition Oesophageal cancer brand patients overall survival rate1 Source: 1. Research trials; 2. Long term reference based on fully developed markets Note: FSMP, Food for Special Medical Purposes
We’ve developed the Right Consumer & Medical Marketing context China, a key short term Maintaining mid-long term Great potential and RTM capabilities to win in China growth engine Leadership to capture new in a shifting opportunities landscape Right Capabilities Medical & Consumer Partnerships with leading retail Data driven marketing route to market and ecommerce players Walmart Group Best Supplier Marketing Partner HCPs consumers Ali Group & patients Supplier of the Year — Golden Award of Data Collab. — Best Integrated MKT MBS Hospita l JD The Only GSKA in IMF MT Pharmacy Ecom Kidswant 1st Brand of IMF
We’re leveraging these skills to capitalize to expand our context short term mid-long term China, a key Maintaining |Great potential market reach and capture opportunities in lower tier cities growth engine Leadership to capture new in a shifting opportunities landscape 1 7 Right Capabilities Dual strategy approach Expanding our market reach Deploying our assets | City coverage (retail) consumers 2015 2016 2017 2018 EST e-RTM e-RTM package for Independent Mom & Baby Stores model HCPs Hospital coverage & patients Patient Digital Medical qualifications journey Education & pharma background management Platforms Therapeutic Area Strong clinical evidence and efficacy Strategy of medical nutrition treatment 2015 2016 2017 2018 EST Source: Internal
We’ve begun to explore opportunities to capitalize on our science and portfolio to support the needs of a large, growing silver demographic Percent of population in 50+ age range Increasing relevance
Allowing us to begin building new platforms to fuel future growth | 29 | Happy mind Pumping heart Inner care Energy & Mobility Never too old for sports
“Specialized Nutrition, giving people the “extra” support they need at critical moments in every stage of life.” first 1000 days childhood adulthood aging
Great Confidence for 2020 and Beyond To contribute to Danone’s objectives our pillars our strategic priorities our 2020 objectives Right Brands accelerate growth & Strategies sales growth (1) Right Right maximize efficiencies Categories Capabilities allocate capital Company objectives with discipline sales growth (1) operating margin (2) (1) Like-For-Like sales growth (2) Recurring operating margin
Disclaimer • This presentation contains certain forward-looking statements concerning Danone. In some cases, you can identify these forward- looking statements by forward-looking words, such as “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “foresee,” “likely,” “may,” “should,” “goal,” “target,” “might,” “will,” “could,” “predict,” “continue,” “convinced,” and “confident,” the negative or plural of these words and other comparable terminology. Forward looking statements in this document include, but are not limited to, statements regarding Danone’s operation of its business, the expected benefits of the transaction, and the future operation, direction and success of Danone’s business. • Although Danone believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward- looking statements. For a detailed description of these risks and uncertainties, please refer to the “Risk Factor” section of Danone’s Registration Document (the current version of which is available on www.danone.com). • Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell, or a solicitation of an offer to buy Danone securities. • All references in this presentation to ”Like-for-like (LFL) New Danone” changes, recurring operating income, recurring operating margin, recurring net income, recurring income tax rate, Recurring EPS, Yakult Transaction Impact, free cash flow and net financial debt correspond to financial indicators not defined in IFRS. Their definitions, their reconciliation with financial statements and IAS29 accounting treatment for Argentina are included in the Q3 sales press release issued on October 17th, 2018. Q1, Q2 and H1 2017 reported figures have been restated for IFRS 15. Indicators ROIC and Net Debt / EBITDA are defined on page 64 of Danone’s 2017 registration document • Due to rounding, the sum of values presented in this document may differ from totals as reported. Such differences are not material.
You can also read